Baudax Bioinc Stock Today
| BXRX Stock | USD 0.01 0.0009 7.83% |
Performance0 of 100
| Odds Of DistressOver 87
|
Baudax BioInc is trading at 0.0106 as of the 19th of April 2024; that is -7.83 percent decrease since the beginning of the trading day. The stock's open price was 0.0115. Baudax BioInc has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Baudax BioInc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 22nd of November 2019 | Category Healthcare | Classification Health Care |
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company was incorporated in 2019 and is based in Malvern, Pennsylvania. Baudax Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 43.59 M outstanding shares of which 493.56 K shares are currently shorted by private and institutional investors with about 0.19 trading days to cover. More on Baudax BioInc
Moving against Baudax Stock
| 0.81 | NUVB | Nuvation Bio Financial Report 2nd of May 2024 | PairCorr |
| 0.64 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.61 | IOVA | Iovance Biotherapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.59 | ZNTL | Zentalis PharmaceuticalsL Financial Report 8th of May 2024 | PairCorr |
| 0.5 | MRSN | Mersana Therapeutics Downward Rally | PairCorr |
| 0.49 | JSPRW | Jasper Therapeutics | PairCorr |
| 0.41 | INZY | Inozyme PharmaInc Financial Report 14th of May 2024 | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Baudax Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Baudax BioInc's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Baudax BioInc or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO President | Geraldine Henwood | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Baudax BioInc report their recommendations after researching Baudax BioInc's financial statements, talking to executives and customers, or listening in on Baudax BioInc's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Baudax BioInc. The Baudax consensus assessment is calculated by taking the average forecast from all of the analysts covering Baudax BioInc. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the measurements of operating efficiency obtained from Baudax BioInc's historical financial statements, Baudax BioInc is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Baudax BioInc is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Baudax BioInc's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Baudax BioInc's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Baudax BioInc's financial leverage. It provides some insight into what part of Baudax BioInc's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Baudax BioInc (BXRX) is traded on NASDAQ Exchange in USA and employs 9 people. Baudax BioInc is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 950.33 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Baudax BioInc's market, we take the total number of its shares issued and multiply it by Baudax BioInc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Baudax BioInc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 43.59 M outstanding shares of which 493.56 K shares are currently shorted by private and institutional investors with about 0.19 trading days to cover.
Baudax BioInc currently holds about 5.65 M in cash with (14.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Baudax BioInc Probability Of Bankruptcy
Ownership AllocationBaudax BioInc holds a total of 43.59 Million outstanding shares. Almost 97.0 percent of Baudax BioInc outstanding shares are held by general public with 0.01 (percent) owned by insiders and only 2.68 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Baudax Ownership Details
Baudax Stock Price Odds Analysis
Based on a normal probability distribution, the odds of Baudax BioInc jumping above the current price in 90 days from now is over 95.16%. The Baudax BioInc probability density function shows the probability of Baudax BioInc stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.3772 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Baudax BioInc will likely underperform. Additionally, baudax BioInc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Baudax BioInc to move above the current price in 90 days from now is over 95.16 (This Baudax BioInc probability density function shows the probability of Baudax Stock to fall within a particular range of prices over 90 days) .
Baudax Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Baudax BioInc that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Baudax BioInc's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Baudax BioInc's value.| Instituion | Recorded On | Shares | |
| Virtu Financial Llc | 2023-12-31 | 0.0 | |
| Sittner & Nelson, Llc | 2023-09-30 | 0.0 | |
| Blackrock Inc | 2023-12-31 | 0.0 | |
| Advisor Group Holdings, Inc. | 2023-12-31 | 0.0 | |
| Xtx Topco Ltd | 2023-12-31 | 0.0 | |
| Creative Planning Inc | 2023-09-30 | 0.0 | |
| State Street Corporation | 2023-12-31 | 0.0 | |
| Susquehanna International Group, Llp | 2023-12-31 | 0.0 | |
| Wells Fargo & Co | 2023-12-31 | 0.0 | |
| Jane Street Group, Llc | 2023-09-30 | 0.0 | |
| Tower Research Capital Llc | 2023-12-31 | 0.0 |
Baudax BioInc Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Baudax BioInc market risk premium is the additional return an investor will receive from holding Baudax BioInc long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Baudax BioInc. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Baudax BioInc's alpha and beta are two of the key measurements used to evaluate Baudax BioInc's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 7.84 | |||
| Standard Deviation | 12.36 | |||
| Variance | 152.74 | |||
| Risk Adjusted Performance | (0.03) |
Baudax Stock Against Markets
Picking the right benchmark for Baudax BioInc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Baudax BioInc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Baudax BioInc is critical whether you are bullish or bearish towards Baudax BioInc at a given time. Please also check how Baudax BioInc's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Baudax BioInc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Baudax BioInc Corporate Management
Elected by the shareholders, the Baudax BioInc's board of directors comprises two types of representatives: Baudax BioInc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Baudax. The board's role is to monitor Baudax BioInc's management team and ensure that shareholders' interests are well served. Baudax BioInc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Baudax BioInc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Natalie McAndrew | Consultant Officer | Profile | |
| Jillian Dilmore | Corp Controller | Profile | |
| Diane Myers | VP Quality | Profile | |
| Mike Choi | Vice Analysis | Profile |
How to buy Baudax Stock?
Before investing in Baudax BioInc, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Baudax BioInc. To buy Baudax BioInc stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Baudax BioInc. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Baudax BioInc stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Baudax BioInc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Baudax BioInc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Baudax BioInc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Baudax Stock please use our How to Invest in Baudax BioInc guide.
Already Invested in Baudax BioInc?
The danger of trading Baudax BioInc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Baudax BioInc is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Baudax BioInc. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Baudax BioInc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Baudax BioInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Baudax BioInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Baudax Bioinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Baudax Bioinc Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Baudax BioInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Baudax Stock please use our How to Invest in Baudax BioInc guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Baudax Stock analysis
When running Baudax BioInc's price analysis, check to measure Baudax BioInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Baudax BioInc is operating at the current time. Most of Baudax BioInc's value examination focuses on studying past and present price action to predict the probability of Baudax BioInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Baudax BioInc's price. Additionally, you may evaluate how the addition of Baudax BioInc to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
Is Baudax BioInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Baudax BioInc. If investors know Baudax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Baudax BioInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (94.13) | Revenue Per Share 0.318 | Quarterly Revenue Growth (0.23) | Return On Assets (1.15) | Return On Equity (47.04) |
The market value of Baudax BioInc is measured differently than its book value, which is the value of Baudax that is recorded on the company's balance sheet. Investors also form their own opinion of Baudax BioInc's value that differs from its market value or its book value, called intrinsic value, which is Baudax BioInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Baudax BioInc's market value can be influenced by many factors that don't directly affect Baudax BioInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Baudax BioInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Baudax BioInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Baudax BioInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.